S&P 500   3,323.22 (+0.51%)
DOW   27,060.75 (+0.87%)
QQQ   270.37 (+0.00%)
TSLA   1,491.84 (+0.33%)
BA   167.22 (+1.30%)
S&P 500   3,323.22 (+0.51%)
DOW   27,060.75 (+0.87%)
QQQ   270.37 (+0.00%)
TSLA   1,491.84 (+0.33%)
BA   167.22 (+1.30%)
S&P 500   3,323.22 (+0.51%)
DOW   27,060.75 (+0.87%)
QQQ   270.37 (+0.00%)
TSLA   1,491.84 (+0.33%)
BA   167.22 (+1.30%)
S&P 500   3,323.22 (+0.51%)
DOW   27,060.75 (+0.87%)
QQQ   270.37 (+0.00%)
TSLA   1,491.84 (+0.33%)
BA   167.22 (+1.30%)
Log in

NASDAQ:NVCNNeovasc Stock Price, Forecast & News

$2.70
+0.01 (+0.37 %)
(As of 08/5/2020 09:44 AM ET)
Add
Compare
Today's Range
$2.70
Now: $2.70
$2.70
50-Day Range
$2.28
MA: $2.45
$2.65
52-Week Range
$1.24
Now: $2.70
$8.65
Volume10 shs
Average Volume231,147 shs
Market Capitalization$30.05 million
P/E RatioN/A
Dividend YieldN/A
Beta2.76
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Read More
Neovasc logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-248-4138

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.09 million
Book Value($1.46) per share

Profitability

Net Income$-35,130,000.00
Net Margins-1,501.37%

Miscellaneous

Employees98
Market Cap$30.05 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable
$2.70
+0.01 (+0.37 %)
(As of 08/5/2020 09:44 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Neovasc (NASDAQ:NVCN) Frequently Asked Questions

How has Neovasc's stock been impacted by COVID-19 (Coronavirus)?

Neovasc's stock was trading at $2.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NVCN stock has increased by 22.2% and is now trading at $2.70.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Neovasc?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Neovasc
.

When is Neovasc's next earnings date?

Neovasc is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for Neovasc
.

How were Neovasc's earnings last quarter?

Neovasc Inc (NASDAQ:NVCN) posted its quarterly earnings data on Thursday, May, 7th. The medical equipment provider reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.17. The medical equipment provider earned $0.53 million during the quarter, compared to analyst estimates of $0.60 million.
View Neovasc's earnings history
.

When did Neovasc's stock split? How did Neovasc's stock split work?

Shares of Neovasc reverse split on the morning of Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

What guidance has Neovasc issued on next quarter's earnings?

Neovasc issued an update on its second quarter 2020 IntraDay earnings guidance on Monday, July, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $295K - 295K.

What price target have analysts set for NVCN?

3 equities research analysts have issued 12-month price objectives for Neovasc's shares. Their forecasts range from $3.00 to $15.00. On average, they anticipate Neovasc's share price to reach $7.67 in the next year. This suggests a possible upside of 184.0% from the stock's current price.
View analysts' price targets for Neovasc
.

Has Neovasc been receiving favorable news coverage?

Media stories about NVCN stock have trended somewhat negative recently, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neovasc earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the immediate future.
View the latest news about Neovasc
.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 195,500 shares, an increase of 5.4% from the June 30th total of 185,500 shares. Based on an average daily volume of 297,700 shares, the short-interest ratio is presently 0.7 days. Approximately 1.4% of the shares of the stock are sold short.
View Neovasc's Current Options Chain
.

Who are some of Neovasc's key competitors?

What other stocks do shareholders of Neovasc own?

Who are Neovasc's key executives?

Neovasc's management team includes the following people:
  • Mr. Fredericus A. Colen, Pres & CEO (Age 66)
  • Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

Who are Neovasc's major shareholders?

Neovasc's stock is owned by a number of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (0.40%).

Which institutional investors are buying Neovasc stock?

NVCN stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $2.70.

How big of a company is Neovasc?

Neovasc has a market capitalization of $30.05 million and generates $2.09 million in revenue each year. The medical equipment provider earns $-35,130,000.00 in net income (profit) each year or ($5.05) on an earnings per share basis. Neovasc employs 98 workers across the globe.

What is Neovasc's official website?

The official website for Neovasc is www.neovasc.com.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.